Inflammatory Effects of a Lung Recruitment Manoeuvre

Prospective, Open, Uncontrolled, Non-randomized and Monocentric Trial on the Efficacy and the Inflammatory Effects of a Lung Recruitment Manoeuvre in Mechanical Ventilated Patients With Respiratory Failure

Recruitment manoeuvres, consisting of sustained inflations at high airway pressures, have been advocated as an adjunct to mechanical ventilation in lung protective ventilation strategies to prevent the collapse of the lung.

This study aims to determine the safety and efficacy of a recruitment manoeuvre, by considering its impact on gas exchange, hemodynamics and on the release of systemic inflammatory mediators.

Study Overview

Detailed Description

This prospective study will analyse the effects of a single recruitment manoeuvre in critically ill patients. Subjects will be mechanically ventilated patients needing alveolar RMs. After a period of stable lung protective approach ventilation, they will receive the "40/30" RM; lung mechanics, gas exchange, hemodynamics and plasmatic concentration of inflammatory mediators will be obtained before and after the RM. An ultrasound score, established from the lung aeration status of upper and lower parts of anterior and lateral chest wall, will also be calculated before and after the manoeuvre.In selected patients cytokine release in the bronchoalveolar lavage will be measured as well.

Study Type

Interventional

Enrollment (Anticipated)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Pisa, Italy, 56126
        • Recruiting
        • U.O. Anestesia e Rianimazione IV, Azienda Ospedaliero Universitaria Pisana
        • Contact:
        • Sub-Investigator:
          • Giuseppe Mancino
        • Principal Investigator:
          • Francesco Forfori
        • Principal Investigator:
          • Antonio Abramo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Mechanical Ventilation
  • Arterial catheter inserted
  • Hypoxemic respiratory failure (Pa02/FiO2 <300)
  • Radiological evidence of atelectasis or pulmonary infiltrates in the CXR
  • Informed consent

Exclusion Criteria:

  • Elevated intracranial pressure >25 mmHg
  • Bronchopulmonary fistula
  • Emphysema
  • Kidney or Liver failure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 40/30 Recruitment Manoeuvre
Patients with respiratory failure that will be first ventilated for 30 minutes according to standardized baseline protective ventilation and after that will receive the recruitment manoeuvre
The ventilator will be switched to the continuous positive airway pressure (CPAP) mode and the pressure will be increased to 40 cmH20 for 30 seconds.
Other Names:
  • PEEP
  • Recruitment Manoeuvres
  • ARDS open lung strategy
continuous positive airway pressure (CPAP)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Plasmatic concentration of inflammatory mediators IL-1, IL-6, IL-8, IL-10, TNFa
Time Frame: T0 (baseline), T4 (3 hrs), T5 (12 hrs)
T0 (baseline), T4 (3 hrs), T5 (12 hrs)
Plasmatic concentration of Nitric Oxide
Time Frame: T0 (baseline), T6 (24 hrs)
T0 (baseline), T6 (24 hrs)
Lung mechanics (Peak pressure, Mean pressure, Compliance, Resistance) Gas exchange (pH, PaO2, PaCO2, HCO3-, SaO2, PaO2/FiO2) Haemodynamics (Mean arterial pressure, Heart rate)
Time Frame: T0 (baseline), T1 (30 secs), T2 (1 hr), T3 (2 hrs)
T0 (baseline), T1 (30 secs), T2 (1 hr), T3 (2 hrs)
Echographic score of lung aeration
Time Frame: T0 (baseline), T2 (1 hr), T4 (3 hrs)
T0 (baseline), T2 (1 hr), T4 (3 hrs)
Chest X-Ray
Time Frame: T6 (24 hrs)
T6 (24 hrs)

Secondary Outcome Measures

Outcome Measure
Time Frame
Levels of IL-1, IL6, IL-8, IL-19, TNFa in the bronchoalveolar lavage
Time Frame: T0 (baseline), T4 (3 hrs)
T0 (baseline), T4 (3 hrs)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Francesco Forfori, UO IV Anestesia e Rianimazione

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

June 1, 2010

Primary Completion (Anticipated)

October 1, 2010

Study Completion (Anticipated)

December 1, 2010

Study Registration Dates

First Submitted

February 16, 2010

First Submitted That Met QC Criteria

February 17, 2010

First Posted (Estimate)

February 18, 2010

Study Record Updates

Last Update Posted (Estimate)

July 7, 2010

Last Update Submitted That Met QC Criteria

July 6, 2010

Last Verified

February 1, 2010

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Insufficiency

Clinical Trials on 40/30 recruitment manoeuvre

Subscribe